158 related articles for article (PubMed ID: 32717612)
1. Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer's disease.
Le-Nhat-Thuy G; Nguyen Thi N; Pham-The H; Dang Thi TA; Nguyen Thi H; Nguyen Thi TH; Nguyen Hoang S; Nguyen TV
Bioorg Med Chem Lett; 2020 Sep; 30(18):127404. PubMed ID: 32717612
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticholinergic activity of 4-hydroxycoumarin derivatives containing substituted benzyl-1,2,3-triazole moiety.
Bagheri SM; Khoobi M; Nadri H; Moradi A; Emami S; Jalili-Baleh L; Jafarpour F; Homayouni Moghadam F; Foroumadi A; Shafiee A
Chem Biol Drug Des; 2015 Nov; 86(5):1215-20. PubMed ID: 26010139
[TBL] [Abstract][Full Text] [Related]
3. Novel Triazole-Quinoline Derivatives as Selective Dual Binding Site Acetylcholinesterase Inhibitors.
Mantoani SP; Chierrito TP; Vilela AF; Cardoso CL; Martínez A; Carvalho I
Molecules; 2016 Feb; 21(2):. PubMed ID: 26861273
[TBL] [Abstract][Full Text] [Related]
4. 5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer's disease modifying agents.
Yazdani M; Edraki N; Badri R; Khoshneviszadeh M; Iraji A; Firuzi O
Mol Divers; 2020 Aug; 24(3):641-654. PubMed ID: 31327094
[TBL] [Abstract][Full Text] [Related]
5. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Edraki N; Sharifzadeh M; Khanavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115
[TBL] [Abstract][Full Text] [Related]
6. Tyrosol 1,2,3-triazole analogues as new acetylcholinesterase (AChE) inhibitors.
Bousada GM; de Sousa BL; Furlani G; Agrizzi AP; Ferreira PG; Leite JPV; Mendes TAO; Varejão EVV; Pilau EJ; Dos Santos MH
Comput Biol Chem; 2020 Oct; 88():107359. PubMed ID: 32853899
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel chromenones linked to 1,2,3-triazole ring system: Investigation of biological activities against Alzheimer's disease.
Saeedi M; Safavi M; Karimpour-Razkenari E; Mahdavi M; Edraki N; Moghadam FH; Khanavi M; Akbarzadeh T
Bioorg Chem; 2017 Feb; 70():86-93. PubMed ID: 27914694
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationship of caffeine-based triazoles as dual AChE and BACE-1 inhibitors.
Sharma M; Sharma A; Nuthakki VK; Bhatt S; Nandi U; Bharate SB
Drug Dev Res; 2022 Dec; 83(8):1803-1821. PubMed ID: 36161804
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors.
Mo J; Yang H; Chen T; Li Q; Lin H; Feng F; Liu W; Qu W; Guo Q; Chi H; Chen Y; Sun H
Bioorg Chem; 2019 Dec; 93():103310. PubMed ID: 31586704
[TBL] [Abstract][Full Text] [Related]
11. 3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes.
Park B; Nam JH; Kim JH; Kim HJ; Onnis V; Balboni G; Lee KT; Park JH; Catto M; Carotti A; Lee JY
Bioorg Med Chem Lett; 2017 Mar; 27(5):1179-1185. PubMed ID: 28189420
[TBL] [Abstract][Full Text] [Related]
12. "Clicking" fragment leads to novel dual-binding cholinesterase inhibitors.
Molęda Z; Zawadzka A; Czarnocki Z; Monjas L; Hirsch AKH; Budzianowski A; Maurin JK
Bioorg Med Chem; 2021 Jul; 42():116269. PubMed ID: 34130217
[TBL] [Abstract][Full Text] [Related]
13. Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Asatouri R; Vafadarnejad F; Moghadam FH; Khanavi M; Sharifzadeh M; Akbarzadeh T
Eur J Med Chem; 2017 Jan; 125():1200-1212. PubMed ID: 27863370
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.
Wu W; Liang X; Xie G; Chen L; Liu W; Luo G; Zhang P; Yu L; Zheng X; Ji H; Zhang C; Yi W
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301153
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB
Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699
[TBL] [Abstract][Full Text] [Related]
17. Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.
Chen Y; Sun J; Peng S; Liao H; Zhang Y; Lehmann J
Arch Pharm (Weinheim); 2013 Dec; 346(12):865-71. PubMed ID: 24203864
[TBL] [Abstract][Full Text] [Related]
18. Design, facile synthesis, and evaluation of novel spiro- and pyrazolo[1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies.
Gálvez J; Polo S; Insuasty B; Gutiérrez M; Cáceres D; Alzate-Morales JH; De-la-Torre P; Quiroga J
Comput Biol Chem; 2018 Jun; 74():218-229. PubMed ID: 29655025
[TBL] [Abstract][Full Text] [Related]
19. Potent acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and docking study of acridone linked to 1,2,3-triazole derivatives.
Mohammadi-Khanaposhtani M; Saeedi M; Zafarghandi NS; Mahdavi M; Sabourian R; Razkenari EK; Alinezhad H; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
Eur J Med Chem; 2015 Mar; 92():799-806. PubMed ID: 25636055
[TBL] [Abstract][Full Text] [Related]
20. Conventional and microwave prompted synthesis, antioxidant, anticholinesterase activity screening and molecular docking studies of new quinolone-triazole hybrids.
Mermer A; Demirbaş N; Şirin Y; Uslu H; Özdemir Z; Demirbaş A
Bioorg Chem; 2018 Aug; 78():236-248. PubMed ID: 29614435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]